Navigation Links
Multi-Year Compendium of Pharmaceutical Case Studies Available from Best Practices, LLC
Date:9/7/2007

CHAPEL HILL, N.C., Sept. 7 /PRNewswire/ -- Pharmaceutical companies face a unique blend of challenges involving balancing new product research, sales and marketing forces, and quality production processes while building and protecting a trusted name in the industry. The case studies in the Multi-Year Compendium of Pharmaceutical Case Studies address these areas and much more. They were presented by industry leaders at Global Benchmarking Council meetings between 2002-2006. This compendium is a valuable tool for any pharmaceutical executive interested in improving communication, marketing and measurement processes, increasing sales, or building a brand.

Topics covered include:

-- Executing Superior Communication to Achieve Superior Sales Performance

-- Innovative Best Practices in Product Re-launches

-- Using Scorecards to Focus Growth in Major Accounts and Best Customers

-- Integrating Process Tools for Enterprise-wide Improvements

-- Enhancing Portfolio Value by Integrating Related Products & Services

"Multi-Year Compendium of Pharmaceutical Case Studies: Meeting Proceedings," is available at http://www.best-in-class.com/dr278.htm.

To access additional findings on topics of interest to the Pharmaceutical industry, consider a membership with the Best Practice Database, an online resource containing more than $35 million in proprietary research conducted on behalf of executives from Fortune 500 companies.

To sign up for a tour of the research documents available in the Best Practices Database, or about the database tours, please click here: http://www3.best-in-class.com/dw212.htm

For more information, contact Grant Houston at 919-767-9182 or at ghouston@best-in-class.com.

ABOUT BEST PRACTICES, LLC

Best Practices, LLC is a research and consulting firm that c
'/>"/>

SOURCE Best Practices, LLC
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Multi-Year Data Shows PAD Treatment Prevents Amputation
2. South Africa Wins landmark case against pharmaceutical giants
3. Pharmaceutical giant offers AIDS related antifungal drug free to 50 countries
4. Pharmaceutical giant offers AIDS related antifungal drug free to 50 countries
5. Setting up a new pharmaceutical industry in India
6. Medicis Pharmaceutical company enters pediatric market
7. Supply of Radiopharmaceuticals Hampered by Attacks
8. Pharmaceutical companies are targeting patients
9. FDA approves Watson Pharmaceuticals Oxytrol patch
10. Ranbaxy Pharmaceuticals Inc awarded the prestigious outstanding supplier award received from Wal-Mart
11. Indian Pharmaceutical Industries Stops Manufacturing And Sale Of Valdecoxib

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...e funds to move lab findings into human therapy fo...from nerve damage ,, ANN ARBOR, Mich., Nov. 9 ...versity of Michigan Department of Neurology have r...erapy for neuropathic pain, a difficult-to-treat c... of damage to nerve without obvious tissue injury....
(Date:11/9/2009)...e in French . , , Montreal, November 9, 2009...ale. In human bodies trillions of cells are couple...re composed. Yet these don,t come in twos, they a...use these complex cell networks are the backbone o... for ways to splice cell clusters down to their or...
(Date:11/9/2009)... 2009 Shire plc (LSE: SHP, NASDAQ: SHPGY), the gl...nounced the availability of INTUNIV (guanfacine) E...nited States for the treatment of Attention-Defici...olescents ages 6 to 17. INTUNIV, a once-daily for...cheduled alpha-2A receptor agonist approved for th...
(Date:11/9/2009)...ple around the world suffer from cataracts. Thomas...his coauthors discuss cataract surgery with the im...sue of Deutsches rzteblatt International ( Dtsch...ndness is usually due to opacification of the lens...rations are performed each year. Cataracts can be ...
(Date:11/9/2009)... people have tried to read Charles Darwin,s "Origi...0th anniversary this month, but gave up. , For t...k is about, help by way of a new book is at hand. ...eznick is the author of "The Origin Then and N...s " (Princeton University Press, 2009), which mak...
Breaking Medicine News(10 mins):Health News:U-M Researchers Receive $1.8 Million Grant to Develop New Therapy for Neuropathic Pain 2Health News:Once-daily INTUNIV (guanfacine) extended release tablets now available in US pharmacies 2Health News:Once-daily INTUNIV (guanfacine) extended release tablets now available in US pharmacies 3Health News:Once-daily INTUNIV (guanfacine) extended release tablets now available in US pharmacies 4Health News:Book by UC Riverside biologist explains Darwin's 'Origin of Species' 2
...disorders among adolescent girls and boys can have...ead to dangerous weight-control behaviors, such as...t pills to control weight. The middle school age i... at the Harvard School of Public Health (HSPH) set...
...d number of youth with office visits with a diagno...tween 1994 and 2003, while adult visits with a bip... according to a report in the September issue of A...a (an abnormally elevated mood) and depression. Al...
... "Psoriasis Cure,Now," a nonprofit patient advoca... parents of children with psoriasis as their kids ...e fact sheet on children,s psoriasis,that parents ...discussing how to treat psoriasis in children and ...
...er 3 KFH has announced that it,has succeeded in o...SO,9001:2000 quality management systems with the B... Director, Dr Sally Sennitt, MD, says: "We are del...d,one that very few young medical device companies...
... data about the safety of drug-,eluting stents (DE...,patients with cardiovascular disease, according t...nterventions (SCAI). These new findings,also under...gimen of medications that prevent blood clots in t...
...fforts to control population growth in the present...s in the future. , This prediction comes from a S...r who spent a year in China studying its geriatric...niversity, said Chinas 1979 policy of limiting cou...
Other Medicine News:Health News:School-based overweight prevention program may cut risk of eating disorders among girls 2Health News:Study documents rapid increase in youth bipolar disorder diagnoses 2Health News:Psoriasis Cure Now offers 'Back to School' Resources for Parents of Children with Psoriasis 2Health News:Latest DES Analysis Stresses Importance of Physicians Well-Trained in Implantation Technique and Patient Follow-Up 2Health News:Latest DES Analysis Stresses Importance of Physicians Well-Trained in Implantation Technique and Patient Follow-Up 3Health News:China's 1-child policy could backfire on its elderly 2Health News:China's 1-child policy could backfire on its elderly 3
(Date:11/9/2009)...ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA ), today...epreve(TM) (bepotastine besilate ophthalmic soluti...were presented in poster sessions at the 2009 Annu...hma & Immunology (ACAAI) in Miami Beach, FL. ...of Ocular Itching with Bepotastine Besilate Ophtha...
(Date:11/9/2009)...ll/ -- Arcadia Resources, Inc. (NYSE Amex: KAD ),...care services under the Arcadia HealthCare(SM) bra...f Directors. Goldsmith will replace Tres Lund who..., (Photo: http://www.newscom.com/cgi-bin/prnh/20...aul Professor of Government and Director of Innova...
(Date:11/9/2009)...ia/ -- Chindex International, Inc.,("Chindex") (Na...ider of Western,healthcare products and services i...results for the second quarter and first half of f... Financial Highlights:, -- Revenue in the seco...on, a year over year basis;, -- Net incom...
Breaking Medicine Technology:ISTA Pharmaceuticals Highlights Bepreve(TM) Clinical Data at the 2009 Annual Meeting of the American College of Allergy, Asthma & Immunology (ACAAI) 2ISTA Pharmaceuticals Highlights Bepreve(TM) Clinical Data at the 2009 Annual Meeting of the American College of Allergy, Asthma & Immunology (ACAAI) 3Arcadia Resources Names Stephen Goldsmith to Board of Directors 2Arcadia Resources Names Stephen Goldsmith to Board of Directors 3Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 2Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 3Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 4Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 5Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 6Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 7Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 8Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 9Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 10Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 11Study of agricultural watersheds and carbon losses 8933 1Study of agricultural watersheds and carbon losses 8933 2Domestication of Capsicum annuum chile pepper provides insights into crop origin and evolution 8931 1Domestication of Capsicum annuum chile pepper provides insights into crop origin and evolution 8931 2Children 26apos 3Bs National Medical Center Dedicates New Blood Donor Center 49506 1Children 26apos 3Bs National Medical Center Dedicates New Blood Donor Center 49506 2Children 26apos 3Bs National Medical Center Dedicates New Blood Donor Center 49506 3
...euticals, Inc. (Nasdaq: ARNA ) announced today th...rial of APD125 in patients with primary,insomnia. ...na with the,potential to reduce insomnia symptoms ...hase 2b trial of APD125 is a double-blind, randomi...ng the efficacy and tolerability of,APD125 in pati...
...Navigenics, a,genetic health services company, tod... analysis. The Mayo Clinic study will examine how ...y a Navigenics genetic risk,assessment. The resear...etic assessments and the impact of such informatio...Proof of Principle Trial of Communication to,Patie...
Other Medicine Technology:Arena Pharmaceuticals Initiates Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia 2Arena Pharmaceuticals Initiates Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia 3Arena Pharmaceuticals Initiates Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia 4Arena Pharmaceuticals Initiates Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia 5Navigenics'(TM) Genome Analysis Used In Research Trial on the Impact of Providing Genetic Risk Assessments 2
Osmetech OPTI CCA Touch
IRMA TRUPOINT Blood Analysis System
Horizon Series Platelet Agitator PF48h
...tors offer a wide range of storage capacities. Del...atform to agitate smoothly, eliminating the need f...y, one-piece perforated drawers with non-slip text...our platelets., ,i.Series platelet agitators f...
Medicine Products: